Clinicotherapeutic evaluation of chlorpropamide, a new sulfonylurea derivative for the treatment of diabetes mellitus. 1959

P SERRANO, and R CHAVEZ

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D002747 Chlorpropamide A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277) Clorpropamid,Apo-Chlorpropamide,Diabinese,Glucamide,Insogen,Meldian
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P SERRANO, and R CHAVEZ
January 1958, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
P SERRANO, and R CHAVEZ
May 1962, Nordisk medicin,
P SERRANO, and R CHAVEZ
January 1973, La Prensa medica mexicana,
P SERRANO, and R CHAVEZ
April 1966, Ugeskrift for laeger,
P SERRANO, and R CHAVEZ
November 1958, Journal of the Irish Medical Association,
P SERRANO, and R CHAVEZ
July 1969, Arzneimittel-Forschung,
P SERRANO, and R CHAVEZ
November 1959, Lancet (London, England),
P SERRANO, and R CHAVEZ
February 1962, La Riforma medica,
Copied contents to your clipboard!